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Ob, jecti es. The aim of this study was to compare the elects of
a phosphodlesterase Inhibitor and catecholamine on arterial .
ventricular coupling and myocardial energetics In the diseased
human heart.
Background. Recent experimental studies have indicated that
the arterial.ventricular coupling analysis using the time-varying
elegance model could discriminate between inotropic and vaso-
active eftts of the two agents .
Methods. With the use of a conductance catheter, left ventric-
ular contractility and arterial afterload were measured from the
slope of the end-systolic pressure-volume relation, E.., and the
slope of the end-systolic pressure-stroke volume relation, E,.
Arterial-ventricular coupling was assessed by E,/E„,„ before and
after administration of a new phosphodiesterase inhibitor, E-1020
(0.3 pgft per min), and a beta,-stimulant, dobutamine (5 pg/kg
per min), in 20 patients with heart disease . Left ventricular
mechanical efficiency was assessed as the ratio of stroke work to
For the treatment of chronic congestive heart failure, ino-
tropic agents yield short-term hemodynamic improvement ;
however, they increase myocardial oxygen consumption and
their long-term benefit is controversial
(1) . In contrast,
vasodilator therapy has gained widespread acceptance for
the treatment of chronic congestive bean failure . Reduction
of inappropriately increased systemic vascular resistance in
congestive heart failure improves cardiac output and reduces
myocardial oxygen consumption
. To use inotropic agents
safely in the clinical setting, it is essential to assess the
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myocardial oxygen consumption per beat measured by the tber-
modilutlou method .
Results. The slope of the end-systolic pressure-volume relation
increased comparably with both E-1020 (39%, p < 0.01) and
dobutamine (47%, p < 0.01), but EM,,. decreased with E-1020
(1.25 to 0.78, -37%, p < 0 .01) more than with dobutamine (1
.23
to 0.99, -16%, p < 0,05). Although stroke work index increased
with both agents, myocardial oxygen consumption remained um
changed with E-1020 but increased with dobutamine (p < 0 .05).
Consequently, left ventricular mechanical efficiency increased
with E-1020 (0.30 to 0.36, p < 0.05) but remained unchanged with
dobutamine (0.27 to 0.29, p = NS).
Conclusions. The phosphodiesterase inhibitor E-1020 Im-
proved arterial-ventricular coupling more than did dobutamine,
with a resultant increase in mechanical efficiency . These data were
In accordance with the theoretic prediction of the coupling anal-
ysis In the diseased human heart .
(I Am Coll Cwv iol 1993 ;22:598-606)
relative contributions of positive inotropism and vasodilative
actions of the agents,
Recent experimental studies (2-6) have indicated that
analysis of arterial-ventricular coupling using the time-
varying elastance model is useful to evaluate the relation
between left ventricular contractility and arterial afterload .
This coupling analysis may have the potential to discriminate
between the positive inotropic and vasodilative effects of
inotropic agents on cardiac output. Furthermore, Burkhoff
and Sagawa (7) demonstrated in their theoretic analysis the
relation between arterial-ventricular coupling and left ven-
tricular mechanical efficiency, defined as the ratio of stroke
work to myocardial oxygen consumption per beat . Thus, this
coupling analysis may be able to provide a better under-
standing of mechanical and energetic consequences of ino-
tropic agents .
In human hearts, although arterial-ventricular coupling at
rest and its response to arterial unloading have been studied
(8,9),
the effect of inotropic agents on arterial-ventricular
coupling has not yrt been investigated . Among clinically
applicable inotropic agents, phosphodiesterase inhibitors
0735-1097193/$6.00
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such as amrinone and milrinone have been shown to have a
positive inotropic effect with remarkable vasodilating effect .
The aim of this study was to compare the effects of a
phosphodiesterase inhibitor and a catecholamine on arterial-
ventricular coupling and myocardial energetics in the dis-
eased human heart . To this end, we studied the newly
developed phosphodiesterase inhibitor E-1020 (10,1 e) and
dobutamine in patients with heart disease .
Methods
Study patients . The study group comprised 20 patients
(15 with previous myocardial infarction and 5 with angina
pectoris, mean age 55 ± 9 years, mean ejection fraction 51
16%) undergoing cardiac catheterization for the evaluation
of ischemic heart disease . Twenty-six patients initially en-
tered the study, but six (two in the dobutamine study and
four in the E-1020 study) did not complete the protocol
because of unsuccessful pressure-volume measurements
during inferior vena cava occlusion . Patients with acute
myocardial infarction, valvular heart disease, idiopathic or
ischemic cardiomyopathy or high risk hemodynamic insta-
bility were excluded . No patient had dyskinetic left ventric-
ular wall motion. Complete informed, written consent was
obtained from each patient before the study and no unfavor-
able complications occurred as a result of this investigation .
The study protocol was approved by the Institutional Com-
mittee on Human Research at Kobe Uni a er-.:*.y Hospital .
Catheterization procedure. All diuretic and vasodilator
medications were withheld for 24 h before the study . An 8F
introducer sheath was placed into the right femorr: artery
and 8F and 9F introducer sheaths were placed into the right
femoral vein with the Seldinger percutaneous technique .
Patients underwent routine catheterization, including coro-
nary angiography and left ventriculography, as previously
described (12,13) . After completion of routine catheteriza-
tion, a 7F thermodilution Swan-Ganz catheter (Goodtech)
was advanced to the pulmonary artery and an 8F conduc-
tance (volume) catheter (CardioDynamics) was advanced to
the left ventricle through the femoral artery . An 8F Webster
catheter (Wilton Webster Manufacturing) was then ad-
vanced into the coronary sinus through the left subclavian
sheath as confirmed by injection of contrast medium .
Left ventricular pressure-volume relations were simulta-
neously determined by the conductance catheter attached to
a stimulator/processor (Sigma-5, CardioDynamics) with a 2F
Millar catheter (Millar Instruments) advanced into the left
ventricle through the lumen of the conductance catheter .
Continuous slow infusion of heparinized saline solution
through the lumen of the conductance catheter was main ..
tained to prevent hemostasis. The principle and accuracy of
left ventricular volume measurement using the conductance
catheter have been described in earlier reports (14-20) and in
our previous study (21) . The indicator technique (injection of
hypertonic saline solution) was used to determine the paral-
lel conductance, that is, the correcting volume for the
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Figure 1 . Representative pressure-volume loops obtained by the
conductance catheter during inferior vena cava occlusion. The slope
of the end-systolic pressure-volume relation (ESPVR), namely,
ventricular elastance (E,,,,x), is a load-independent index of myocar-
dial contractility and the volume-axis intercept of this relation .
conductance of the surrounding tissues . If the parallel con-
ductance was not obtained appropriately, we calibrated the
conductance signal by the biplane cineventriculographic
volume data u3ing the area-length method previously de-
scribed in detail (13) .
Assessment of lit ventricular contractility . After comple-
tion of calibrations, a large balloon occlusion catheter (Bax-
ter) was advanced to the right atrium just above the inferior
vena cava to occlude venous return . Pressure-volume loves
for the sequence
of the beats after the reduction in preload
resulting in a 30- to 40-mm Hg decrease in left ventricular
systolic pressure were recorded over 8 to 10 beats . This
procedure was repeated several times to obtain the end-
systolic pressure--volume relation (Fig. 1) (17,18) . The left
ventricular pressure-volume data during the decrease in left
ventricular pressure were fit using the least-squares tech-
nique to determine :
ESP = Em, (ESV - V0), (1)
where ESP is the left ventricular end-systolic pressure,
Emax
is the slope of the linear end-systolic pressure-volume rela-
tion, ESV is end-systolic volume and Vo is the intercept of
the volume axis (22-24) ; Emax (in mm Hg1ml) has been
applied to the left ventricle of the intact animal and the
human as a load-independent index of myocardial contrac-
tility (25-33) . We normalized E . .,, (mm Hg/m1 per in') and
Vo (ml/m2) for body surface area to permit comparison
among patients in the present study, as described in an
earlier report (28) .
Arterial-ventricular coupling. We used the concept of the
coupling between the left ventricle and the arterial system
proposed by Sunagawa et al . (2-4) . They characterize left
ventricular properties by ventricular elastance (E„ mx ) and
arterial properties by effective arterial elastance (E,) . The
latter incorporates the principal elements of vascular load,
including peripheral resistance, vascular compliance, char-
acteristic impedance and systolic and diastolic time intervals
(2-4) . This variable can be approximated by the steady state
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Figure 2. Representative pressure-volume diagram showing the
method of calculating systolic pressure-volume area (PVA). This
variable was calculated as the area circumscribed by the end-
systolic pressure-volume relation assessed by inferior vena cava
occlusion, end-diastolic pressure-volume relation and the systolic
pressure-volume trajectory of a steady state contraction . The
pressure-volume area consists of potential energy (PE) and stroke
work (SW) and has been considered to represent the total mechan-
ical energy generated by contraction. Effective arterial elastance
(En ) is the slope of the arterial end-systolic pressure-stroke volume
relation that characterizes the arterial impedance and corresponds
to the slope of the line connecthlg the end-systolic pressure-volume
point and end-diastolic volume point on the volume axis .
ratio of end-systolic pressure to stroke volume (ESPISV) and
currespunds iii the slope of the iifle conuectui the end-
systolic pressure-volume point and end-diastolic volume
point on the volume axis as shown schematically in Figure 2 .
The ratio of effective arterial elastance to ventricular
elastance (Ea/E...) represents arterial-ventricular coupling .
Calculation of pressure-volume area . This variable (in
mm Hg-ml) was calculated as the area that is hounded by the
end-systolic and end-diastolic pressure-volume relations
and the systolic pressure-volume trajectory of each beat
(Fig. 2) (24) . It consists of potential energy (triangular area
on the pressure-volume plane) and stroke work and has been
considered to represent the total mechanical energy gener-
ated by eoinrsctior ('14) . The dimensiorl)esc ratio of etrnke
work to pressure-volume area (SW/PVA) represents the
energy transduction from the total mechanical energy to the
external work output and is dependent on arterial-
ventricular coupling, In this study, stroke work was calcu-
lated as the area surrounded by the pressure-volume loop
during one cardiac cycle .
Measurement of myocardial oxygen consumption and me-
chanical efficiency. With the Webster catheter advanced into
the coronary sinus, coronary sinus blood flow was measured
at least twice during a 30-s continuous injection of room
temperature indicator (5% glucose) through the catheter
lumen at a rate of 40 ml/min with use of a Mark IV
angiographic injector (Medrad) . Coronary sinus flow mea-
surements were performed with
previously established
methods (34-36) . Coronary venous blood was sampled from
the distal lumen of the Webster catheter for oximetry and
determination of myocardial oxygen consumption . Myocar-
dial oxygen consumption per minute was calculated as the
product of coronary sinus flow (in ml/min) and coronary
sinus-arterial oxygen content difference (vol%) divided by
heart rate to yield myocardial oxygen consumption per beat
(ml 0
2
-beat-1). We calculated left ventricular mechanical
efficiency as the ratio of stroke work (in J-beat - ') to myo-
cardial oxygen consumption per beat (in J-beat'), where
l mm Hg-ml of stroke work and 1 ml 02 of oxygen consump-
tion correspond to 1.33 x 10-4 and 20 J, respectively . Thus,
the mechanical efficiency is dimensionless .
Theoretic prediction of mechanical efficiency . Sunagawa
et al . (2-4) considered left ventricular stroke work at a
constant end-diastolic volume and ventricular elastance
as a function of the ratio of effective arterial elastance
to ventricular elastance (Ea/Ema,) . Briefly, stroke work (SW)
is expressed as :
SW = ESP - SV = En - (EDV - V0)2/( l + Emnx/En)2 . [21
where EDV is the end-diastolic volume and SV is stroke
volume. This equation predicts that the stroke work should
be maximized when effective arterial elastance equals ven-
tricular elastance .
Burkhoff and Sagawa (7) considered left ventricular me-
chanical efficiency, defined as the ratio of stroke work to
myocardial oxygen consumption per beat as a function of the
ratio of effective arterial elastance to ventricular elastance .
Briefly, as shown in Figure 2, systolic pressure-volume area
(PVA) is the sum of stroke work and potential energy . The
linear relation that Suga et al . (24) demonstrated between
pressure-volume area and myocardial oxygen consumption
per beat (Vo 2 ) is characterized by a slope (A) and an
intercept (B), so that:
Vo2 7 A •PVA + B . [3)
Left ventricular mechanical efficiency (SW/Vo 2 ) at a given
end-diastolic volume and ventricular elastance is obtained
by :
SW/Vo2 = U[A - (I + En/2E=,,)
+ B - (I + EJEa,a,,)2/Enl(EDV - V0)2) . [4)
Burkhoff and Sagawa (7) predicted that left ventricular
mechanical efficiency should be maximized when the effec-
tive arterial elastance approximates 50% of ventricular
elastance in dog heart experiments . As shown in Figure 3,
we obtained similar results and confirmed their hypothesis
by giving the representative values in the present study for
Ema„ (5 mm HS/ml per m2), Vo (10 ml/m2), end-diastolic
volume (120 ml/m) and mean values of the variables of the
human oxygen consumption per beat/pressure-volume area
relation obtained in our previous study (37) for A (0 .0000182
ml 021[mm Hg(mlj) and B (0.0284 ml 02ibeat) .
Study protocol. After adequate placement of the conduc-
tance catheter, blood resistivity (p) was measured and en-
tered into the signal coordinator and volume correction by
the parallel conductance was performed . Right atrial pacing
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Figure 3. Theoretic prediction of mechanical and energetic effects
determined by arterial-ventricular coupling analysis using the time-
varying elastance model in the framework proposed by Sunagawa et
al . (2-4 ; and Burkhoff and Sagawa (7)- Stroke work (SW, closed
circles) at a given end-diast^tic volume obtained by equation 2 is
maximal when the effective arterial elastance/ventricular elasance
ratio, an index of arterial-ventricular coupling, equals unity . We
simulated left ventricular mechanical efficiency, defined as the ratio
of stroke work to myocardial oxygen consumption per beat (SW)
Vo2, open squares), as a function ofthe effective arterial elastancel
ventricular elastance ratio according to equation 4 and found that
the efficiency is maximal when the effective arterial elastancel
ventricular elastance ratio is -0.5 .
was then started by the tipped electrodes on the Webster
catheter at a fixed heart rate approximately 10 beats/min
higher than the baseline heart rate (85 ± 9 beats/min for
dobutamine and 83 ± 4 beatslmin for E-1020) . After steady
state systemic and coronary hemodynamics and pressure-
volume loops were measured, transient vena caval occlu-
sions were performed to obtain the end-systolic pressure-
volume relation during control conditions .
Dobutamine study.
After control measurements, a con-
tinuous infusion of dobutamine at a rate of 5 ,ug/kg per min
was administered in 10 patients . Similar measurements were
made 10 miii after time start of the infusion .
E-1020 study .
In the other 10 patients, a continuous
infusion of E-1020 was administered at a rate of 7. pg/kg per
min during the initial S min and then at a rate of 0 .3 ug/kg per
min. We chose these doses of E-1020 to obtain increases in
ventricular elastance as comparable to those obtained during
dobutantine infusion at a rate of 5 µg/kg per min . Measure-
ments similar to those in the dobutamine study were per-
formed during control conditions and 30 min after the start of
the E-1020 infusion .
Statistics. We obtained the end-systolic pressure-volume
relations by linear regression analysis . Paired variables
before and after administration of dobutamine or E-1020
were compared by Wilcoxon signed-rank
test with the
Bonferroni correction. An unpaired t test was applied to
compare the variables in the dobutamine and E-1020 studies .
Differences were considered significant at a p value < 0 .05
.
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Results
There was no difference in mean age (47 ± 20 vs . 54 . 11
years, p = NS) between the dobutamine and E-1020 study
groups . All patients in both groups were male . The dobu-
tamine study group consisted of four patients with angina
pectoris and six with previous myocardial infarction . The
E-1020 study group consisted of one patient with angina
pectoris and nine patients with previous myocardial infarc-
tion. The hemodynamic variables during control conditions
did not differ between the two groups .
Effect of dobutamine and E-1020 on hemodynamic vari-
ables (Table 1). When dobutamine was administered, end-
systolic pressure, cardiac index, stroke work index, ejection
fraction and pressure-volume area increased. There was no
significant change in heart rate, end-diastolic pressure, end-
diastoh.. volume index, end-systolic volume index or pulmo-
nary artery wedge pressure .
When E-1020 was administered, stroke work index, ejec-
tion fraction and cardiac index increased . In contrast to
results with dobutamine, end-systolic, end-diastolic and
pulmonary artery wedge pressures decreased . There was no
significant change in heart rate, end-diastolic or end-systolic
volume index or pressure-volume ea. The E-1020 and
dobutarnine groups did not differ in increases in ejection
fraction (+10 ± 13% units vs. +12 ± 14% units, p = NS) or
cardiac index (+13 ± 18% vs . +9 ± 13%, p = NS) .
Effect of E-1'120 and dobutamine on myocardial energetics
(Table 1) . Dobutamine resulted in increases in coronary
sinus flow (+34 ± 37%) and myocardial oxygen consumption
(+33 ± 37%). In contrast, coronary sinus flow (+ 10 ± 30%)
and myocardial oxygen consumption (-5 ± 21%) were not
significantly changed with E-1020 .
Effect of dobutamine and E-1020 on the arterial-ventricular
coupling and efficiency (Fig . 4). Figure 4 shows the effect of
dobutantine and E-1020 on ventricular elastance (panel A),
effective arterial elastance (panel B), the ratio of effective
arterial elastance to ventricular elastance (panel C), the ratio
of stroke work to pressure-volume area (panel D) and left
ventricular mechanical efficiency (panel E) . Ventricular
elastance increased with dobutantine (3.43 ± 2 .04 to 4
.70
2.23 mm Hg/ml per m2, 47 ± 35%, p < 0
.01) and E-1020
(3.04 ± 0 .79 to 4 .18 ± 0.92 mm Hg/ml per m', 39 ± 15%, p <
0.01). The intercept of the volume axis
id not change
significantly with either dobutamine (8 ± 64 to -9
18 mI/m2 , p = NS) or E-1020 (12 ± 35 to 26 ± 41 mI/m
2 , p =
NS). The effective arterial elastance remained unchanged
with dobutamine (3.48 ± 1 .01 to 3 .96 ± 1 .04 mm Hg/ml per
m2 , p = NS) but decreased with E-1020 (3
.69 ± 0.86 to
3 .19 ± 0.96 mm 11g/ml per m 2 , p < 0.05)
. As a result, the
ratio of effective arterial elastance to ventricular elastance
improved with both dobutamine (1 .23 ± 0.52 to 0 .99 ± 0.45,
p < 0.05) and E-1020 (1 .25 ± 0.30 to 0 .78 ± 0.22, p < 0
.01),
but the improvement was larger with E-1020 than with
dobutamine (37 ± 14% vs
. 16 ± 29%, p < 0 .05). The stroke
work/pressure-volume area ratio remained unchanged with
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Table 1. Effect of Dobutamine and E-1020 on Myocardial Mechanics and Energetics
"'p
< 0,05, tp < 0,01 versus value before drug administration . Values are expressed as mean value ± SD. After =
after administration of inotropic agent ; Before
-
before administration of inotropic agent ; CI = cardiac index ; CSF
coronary sinus flow ; EDP
-
and-diastolic pressure ; EDVI
-
end-diastolic volume index
: EF = ejection fraction (%);
ESP
-
end-systolic pressure ; ESVI -
end-systolic volume Index
; HR
-
heart rate ; PCP = pulmonary artery wedge
pressure; PVA - systolic pressure-volume area ; SWI
a
stroke work index ; Va t = myocardial oxygen consumption
per beat.
dobutamine (0.56 ± 0 .16 to 0.63 t 0.19,18 ± 40%, p = NS)
but increased with E-1020 (0.53 ± 0.13 to 0.70 ± 0.07, 46
72%, p < 0.05). The stroke work/myocardial oxygen con.
sumption ratio remained unchanged with dobutamine
(0.27 ± 0.14 to 0.29 ± 0.14, p = NS) but increased with
E-1020 (0.30 t 0 .12 to 0.36 ± 0.13, p < 0 .05) .
Comparison of the relation between stroke work/pressure-
volume ratio and the effective arterial elastancelventricular
elastance ratio between control patients and those with heart
failure. To test whether the coupling analysis is applicable
to the patients with congestive heart failure whose ejection
and filling portions of the pressure-volume loop are not flat,
we compared the str-,1 -e work/pressure-volume ratio and the
effective arterial elastance/ventricular elastance ratio be-
E-1020
8
E os
OA
0.4
E
art
ao
Dab E-1.020
Dob E-1020
0
tween control patients and those with mild to moderate heart
failure . Table 2 compares the mean values of hemodynamic
variables before administration of dobutamine and E-1020
between the two groups. The control group consisted of nine
patients with a normal ejection fraction (>50%). The heart
failure group consisted of l 1 patients with a reduced ejection
fraction (<50%). Ejection fraction was significantly lower
(75 ± 8% vs . 38 t 6%, p < 0.001) and end-diastolic and
end-systolic volume indexes were significantly greater in the
heart failure group than in the control group . Ventricular
elastance tended to be lower and pulmonary artery wedge
pressure higher in the heart failure group .
The left panel in Figure 5 shows that there was a close
correlation between the stroke work/pressure-volume and
Dob E-1020
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Figure 4. Changes in ventricular elastance (F,,, a')
(panel A), effective arterial elastance (E *} (panel
B), the effective arterial elastance/ventricular
elastance ratio (E)E1*x ) (panel C) . stroke work/
pressure-volume area ratio (SW/PVA) (panel D)
and stroke worklmyocardial oxygen consumption
ratio (SW/Vo2) (panel E) after administration of
dobutamine (Dob) and E-1020 . Ventricular
elastance increased to the same extent, wherea,;
the effective arterial elastance decreased with
E-1020 but remained unchanged with dobutamine .
As a result, both agents decreased the effective
arterial elastance/ventricular elastance ratio, but
the decreases were significantly larger with
E-1020. In ecordance with the changes in the
effective arterial elastance/ventricular elastance
ratio, stroke work/pressure-volume area ratio and
stroke worklmyocardial oxygen consumption ra-
tio increased with E-1020 but remained unchanged
with dobutamine . *p < 0.05, **p < 0.01 versus
before drug administration .
Dobutamine (n = 10) E- 1020 (n = 10)
Before After Before After
HR (beatslmin) 85 ± 9 87 ± 8 83 ± 4 86 t 10
PCP (mm Hg) 14
± 10 13 ± 5 14 ± 7
10 ± 5*
C1 (ml/min per m2) 3 .20
± 0 .75 3 .46 ± 0 .7311 3 .18 ± 0.87 3.59 t 1 .06*
ESP (mm Hg) 125 ± 18 152 .1 231' 136 ± 24 125 ± 19*
EDP (mm Hg)
18 t 7 20 :t 9
24 ± 6
19
± 71
EDVI (mYne)
101 ± 37 98 ± 40 102 ± 29 102 ± 33
ESVI (mI/0 )
63 t 43 58 t 44 6.' t 31 60 ± 34
EF (%) 43 ± 19
47 ± 19*
40 t 14 44 ± 17*
SWI (mm Hg-ml/m2 )
4 .025 ± 1,544 5,522 t 1,9831 4,049 t
1 .646 4 .521 w 1,826*
PVA (mm Hg-ml)
12,340 -14.930 13,902 t 4,467* 13,517 ± 5,472 11,226 x 5,029
CSF (ml/min) 137 145 173 t 391 137 t 42 146 t 45
V0
2 (ml O2lbeat) 0 .17 t 0.06 0.21 t 0.05 0 0.16 ± 0.06 0.15 ± 0 .05
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Table 2. Hemodynamic Data in the Control and Heart
Failure Groups Before Administration of Inotmpic Agents
*p < 0
.001 versus control
g roup
. t p < 0
.05 versus control group . Values
are expressed a :, mean value t SD . Control Group = patients with an ejection
fraction X50%; heart failure group = patients with mild to moderate heart
failure (ejection fraction <50%) . Abbreviations as in Table 1 .
the effective arterial clastance/ventricular elastance ratios in
pooled data (r = -0.59, p < 0 .0001). Furthermore, there was
no significant difference in the correlation of these two ratios
between the control (middle panel) and heart failure (right
panel) groups .
Discussion
In the present study, we investigated the effect of two
inotropic agents---a new phosphodiesterase inhibitor,
E-1020, and dobutamine.-on arterial-ventricular coupling
and myocardial energetics in patients with variably de-
pressed ventricular function . Both drugs increased stroke
work index, cardiac index and ventricular elastance to the
same extent but E-1020 improved arterial-ventricular cou-
pling and left ventricular mechanical efficiency more than did
dobutamine .
Effect of botropic agents on arterial-ventricular coupling .
E-1020 is a newly developed imidazopyridine derivative
(10,11) . Intracellular cyclic adenosine monophosphate accu-
mulated by phosphodiesterase inhibition mediates the posi-
tive inotropic effect of bipyridine derivatives (10,11) . E- 1020
has been shown to have a positive inotropic effect with little
increase in heart rate and a remarkable vasodilating effect in
the heart of the closed chest dog with pacing-induced heart
failure (38) . In the present study, E-1020 reduced left ven-
tricular preload in terms of end-diastolic pressure and pul-
monary artery wedge pressure more than did dobutamine,
but it increased cardiac index to the same extent as dobu-
tamine. Despite the greatly reduced preload, increased car-
diac index with E-1020 may be related to the reduction of left
ventricular afterload in terms of end-systolic pressure with
E-1020 . These results indicate that E-1020 has a remarkable
vasodilating effect even in the diseased human heart . How-
ever, these hemodynamic variables do not have the capacity
to discriminate between the relative contributions of positive
inotropism and vasodilating action on cardiac output .
It is clinically important to quantify the positive inotropk
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and vasodilative actions of an agent in patients with heart
disease. Positive inotropic stimulation increases myocardial
oxygen demand in proportion to
an increase in contractile
force, whereas a vasodilating effect decreases myocardial
oxygen demand in proportion to the reduction of myc ,ardial
wall stress . Measured myocardial oxygen consumption may
reflect the net effect of both
. It is clear that the load-
dependent indexes of myocardial contractility such as ejec-
tion fraction or mean velocity of circumferential fiber short-
ening are not suitable for quantifying the inotropic action of
an agent when it changes systolic and diastolic loading
conditions . Arterial-ventricular coupling analysis using the
time-varying elastance model of both the left ventricle and
the arterial system proposed by Sunagawa et al . (2-4) could
quantify the isotropic state of the left ventricle and arterial
afterload. Myocardial inotropic state was quantified by the
relatively load-independent index of contractility, that is, left
ventricular clastance and the arteria) afterload was quanti-
fied by the effective arterial elastance . The latter variable can
easily be obtained as the ratio of end-systolic pressure to
stroke volume (2-4) and incorporates an important addi-
tional influence of pulsatile impedance load tha, cannot be
indexed by mean resistance (39) .
Several experimental studies have been performed to
elucidate the optimal coupling between the arterial system
and left ventricle in vivo . In isolated cat hearts. Elzinga and
Westerhof (40) showed that maximal mean external power,
oxygen consumption and mechanical efficiency of left ven-
tricular contraction were achieved at different o'
nei-Atinp
points on their ventricular pump function graph relating
mean left ventricular pressure and mean flow . van den Horn
et al. (41) and Toorop et al . (42) recently demonstrated that
in anesthetized open{ chest cat hearts, the left ventricle
operates at the point of maximal external power rathe : than
efficiency on the ventricular pump function graph . They
defined this eundition as matching . This matching of heart
and periphery has been achieved under a variety of condi-
tions in vivo, although some interventions (such as norepi-
nephrine infusion) caused a mismatch (43) . Similarly, Suna-
gawa et al. (5) showed that the normal left ventricle is
adapted to its arterial afterload to yield maximal stroke work
from a given end-diastolic volume in intact conscious dog
hearts. Most previous experimental studies pruuuccd he
similar finding that physiologic states of the left ventricle and
arterial system are coupled to produce maximal stroke work
or power.
Effect of inotropic agents on myocardial energetics . In the
framework of the arterial-ventricular coupling analysis pro-
posed by Sunagawa et al . (2-4), the effective arterial
elastance/ventricular elastance ratio equals unity when the
left ventricle is adapted to its afterload to yield maximal
external work output as illustrated in Figure 3 . They (5)
confirmed this hypothesis experimentally under a variety of
conditions in vivo. Theoretically, the heart can transduce
more energy from the pressure-volume area (total mechani-
cal energy) to external work output in proportion to a
Control Group
(n
= 9)
Heart Failure
Group
(n =
11)
Age (yr) 53 ± 17 i4 t !6
EF (%)
75 t 8 38 t 6*
PCP (mm Hg) 11 t 6 17 t 9
CI (mllmin per m°) 3 .04 t 0 .51 2 .60
±
0 .54
ESP (mm Hg) 141 t 20 123 ± 19
EDP (mm Hg) 18 t 7 23 ± u
EDVI (mum') 135
t
36 156 ± 37t
ESVI (mlfm2) 31 ± 7 86 ± 29*
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decrease in the effective arterial elastance/ventricular
elastance ratio. Our findings that E-1020 decreased the
effective arterial elastancelventricular elastance ratio and
increased stroke work/pressure-volume area more than did
dobutamine are in accordance with this hypothesis . Burkhoff
and Sagawa (7) extended this framework to myocardial
energetics. In their theoretic study, they showed that the
effective arterial elastance/ventricular elastance ratio is ap-
proximately 0.5 when the left ventricle is adapted to its
afterload to yield maximal left ventricular mechanical effi-
ciency. As illustrated in Figure 3, we simulated the relation
between left ventricular mechanical efficiency and the effec-
tive arterial elastancelventricular elastance ratio by using the
representative values obtained in the present study and our
previous study (37) (equation 4) and obtained similar results .
When myocardial oxygen consumption was directly mea-
sured by the thermodilution method, E-1020 decreased the
effective arterial elastance/ventricular elastance ratio toward
0.78 and increased left ventricular mechanical efficiency
significantly. These results were also in accordance with
their theoretic prediction .
For the better understanding of the energetic effect of
E.1020 distinct from that of dobutamine in the present study,
the concept of the myocardial oxygen consumption/
pressure-volume area relation proposed by Sup (24) is
helpful. The linear relation between myocardial oxygen
consumption and pressure-volume area under a variety of
loading conditions has been reported tn animal experiments
(24) and in our previous studies in patients (37,44,45) .
Inotropic intervention, which increase the ventricular
elastance, shifts the linear myocardial oxygen consumption-
pressure-volume area relation upward in a parallel manner
so that the production of the same pressure-volume area
requires greater myocardial oxygen consumption (that is,
pressure-volume areaindependent myocardial oxygen con-
sumption increases) (24,44,45) . These increases in pressure-
volume areaindependent myocardial oxygen consumption
would be expected to reduce left ventricular mechanical
efficiency. Conversely, a decrease in the effective arterial
elastance'/venaricular elastance ratio (improvement of arterial-
ventricular coupling) increases the energy transfer from
heart failure
1 2
Ea/Emaa
Figure 5. Relation between stroke work/
pressure-volume area and the effective arterial
elastance/ventricular elastance ratio (EA,,,,,) in
pooled data (left pant), the control group (ejec-
tion fraction >50%) (middle panel) and in the
group with mild to moderate heart failure (ejec-
tion fraction <50%) (right panel) . There was
close correlation between stroke work/pressure-
volume
area and the effective arterial elastance/
ventricular
elastance ratio in the pooled data.
Furthermore, the correlation did not differ sig-
nificantly between the control and heart failure
groups. post = after administration of the iso-
tropic agents ; pre = before administration of the
inotrapic agents .
pressure-volume area to stroke work and would be expected
to improve left ventricular mechanical efficiency . The con-
siderable decrease in the effective arterial elastance/
ventricular elastance ratio with E- 1020 may have resulted in
increase' mechanical efficiency . The lesser decrease in the
effective arterial elastance/ventricular elastance ratio with
dobutamine infusion compared with that induced by E-l 20
may have been offset by the positive inc tropism, which
decreases mechanical efficiency .
Another possible explanation of why E-1020 increased
left ventricular mechanical efficiency might be the lesser
increases in pressure-volume area-independent myocardial
oxygen consumption with E-1020 compared with those
induced
with dobutamine. Because ventricular elastonce
increased to the same extent with the two agents in the
present study, a lesser increase in pressure-volume area-
independent myocardial oxygen consumption would be in-
terpreted as a lower ttonmechanical oxygen consumption per
unit increase in ventricular elastance (that is, a lesser oxygen
cost of ventricular elastance) (46). However, a previous
report (47) showed that the oxygen cost of ventricular
elastance was the same in catecholamines and phosphodies-
terase inhibitor. Therefore, it is likely that the greater
decrease in the effective arterial elastancelventricular
elastance ratio with E- 1020 than with dobutamine may be the
major mechanism for the increase in mechanical efficiency .
lnotropic agents that have both greater vasodilating ef-
fects and less arrhythmogenic effects may be suitable for the
treatment of chronic congestive heart failure . The use of
E-1020 resulted in positive inotropism but did not increase
heart rate or ventricular arrhythmias in this study . Although
we did not investigate the long-term benefit of E-1020, our
results suggest that E-1020 may be a suitable alternative to
catecholamines, at least in short-term therapy .
Study limitations . Our study has some limitations . 1) As
Sunagawa et al. (2) pointed out, the assumption that ejection
portion of the pressure-volume loop
is flat and left ventric-
ular diastolic pressure is negligible would affect the estima-
tion of stroke work in some patients . These assumptions
would not be correct in patients with heart failure . To test
whether the coupling analysis is applicable to the patients
JACC Vol . 22, No . 2
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with heart failure whose ejection and filling portions of the
pressure-volume loop are not flat, we compared the stroke
work/pressure-volume area ratio versus the effective arterial
elastancelventricular elastance ratio relation between a con-
trol group (ejection fraction 75 ± 8%) and a group with mild
to moderate heart failure (ejection fraction 38 ±
6%) . Figure
5 shows that there was a good correlation between the
effective arterial elastance/ventricular elastance ratio and
stroke work/pressure-volume area ratio in pooled data
and no difference between the correlation in the control and
heart failure groups . Therefore, the possible error in the
estimation of the stroke work in patients with heart failure
may be small .
2) We examined only two drugs in the present study .
Recently, several new inotropic agents such as forskolin
and calcium sensitizer have been developed and some of
these agents have become clinically available . Further study
is needed to validate this coupling analysis in clinical set-
tings .
3) Some errors may have occurred because we assumed a
linear end-systolic pressure-volume relation . The negative
volume intercept of the end-systolic pressure-volume rela-
tion was observed in some patients in the present study and
in earlier experimental and clinical studies (17,47) . The
extrapolation of the linear end-systolic pressure-volume
relation from a relatively narrow range of data may yield a
negative intercept of the volume axis . Although end-systolic
pressure-volume relation over a wide pressure-volume
range may be nonlinear even in humans, Little et al . (26)
observed that this nonlinearity did not prevent the end-
systolic pressure-volume relation from being well approxi-
mated by a straight line or the ventricular elastance from
providing a sensitive and consistent index of the contractile
state .
4) We must consider myocardial ischemia due to iso-
tropic agents because we studied patients with ischemic
heart disease. However, there was neither chest pain, ST
segment depression on the electrocardiogram or an increase
in end-diastolic pressure, which suggests myocardial isch-
emia.
Conclusions . The present study shows that, compared
with dobutamine, the new phosphodiesterase inhibitor
E-1020 decreased the effective arterial elastance/ventricular
elastance ratio and improved left ventricular mechanical
efficiency, findings in accordance with arterial-ventricular
coupling analysis . Our results suggest that E • 1020 may be an
alternative to catecholamines, and the arterial-ventricular
coupling analysis may explain the energetic effect of inotrop-
ic agents within the limited ranges of contractility and
loading conditions in the diseased human heart .
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